Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 268,677 | 707,913 | 592,722 | 793,618 | 281,941 |
| Marketable Securities | 2,270,944 | 1,603,120 | 1,067,554 | 995,656 | 1,189,826 |
| Receivables | 433,633 | 396,125 | 400,623 | 371,984 | 385,444 |
| Inventories | 224,372 | 216,903 | 174,040 | 166,060 | 135,506 |
| Income taxes - deferred | 97,905 | 84,839 | 13,818 | 16,894 | 33,001 |
| Other current assets | 40,769 | 34,925 | 15,430 | 0 | 0 |
| TOTAL | $3,375,405 | $3,092,208 | $2,297,715 | $2,384,820 | $2,070,244 |
| Non-Current Assets | |||||
| PPE Net | 240,587 | 242,568 | 238,310 | 237,221 | 225,428 |
| Other Non-Current Assets | 420,542 | 431,540 | 382,660 | 66,073 | 73,811 |
| TOTAL | $661,129 | $674,108 | $620,970 | $303,294 | $299,239 |
| Total Assets | $4,036,534 | $3,766,316 | $2,918,685 | $2,688,114 | $2,369,483 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 60,374 | 60,206 | 118 | 141 | 161 |
| Accounts payable and accrued liabilities | 60,209 | 70,908 | 33,134 | 57,704 | 35,862 |
| Accrued Expenses | 62,864 | 70,441 | 65,551 | 48,919 | 47,993 |
| TOTAL | $421,903 | $465,163 | $267,866 | $261,190 | $270,219 |
| Non-Current Liabilities | |||||
| Long Term Debt | 184,382 | 240,650 | 291 | 293 | 259 |
| Deferred Revenues | 12,881 | 18,353 | 11,625 | 15,839 | 15,112 |
| Other Non-Current Liabilities | 10,049 | 0 | -1,465 | -743 | 115 |
| TOTAL | $226,218 | $273,375 | $32,489 | $34,150 | $35,912 |
| Total Liabilities | $648,121 | $738,538 | $300,355 | $295,340 | $306,131 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,820,064 | 1,849,139 | 1,831,674 | 1,823,712 | 1,807,247 |
| Common Shares | 463 | 460 | 457 | 455 | 451 |
| Retained earnings | 1,072,346 | 809,642 | 528,040 | 348,808 | 152,841 |
| Other shareholders' equity | -2,473 | 11,448 | 9,197 | 12,185 | -868 |
| TOTAL | $3,388,413 | $3,027,778 | $2,618,330 | $2,392,774 | $2,063,352 |
| Total Liabilities And Equity | $4,036,534 | $3,766,316 | $2,918,685 | $2,688,114 | $2,369,483 |